Epiphany Biotech offers a contract research and development service that moves therapeutic or diagnostic candidates from target identification to early pre‑clinical validation using high‑throughput screening, bioinformatics, and GLP/GMP‑compliant assay platforms. The company provides integrated protein expression, data analytics via a secure cloud portal, and regulatory consulting to streamline IND preparation. Its clients include biotech startups, pharmaceutical R&D divisions, and academic research groups.
Funding
Funding not disclosed
Founders
Product
Problem
Biotechnology firms often struggle to translate biological discoveries into viable therapeutic or diagnostic products due to high R&D costs, lengthy development timelines, and complex regulatory requirements. Limited in‑house capabilities can delay candidate validation and increase the risk of project failure.
Solution
Epiphany Biotech provides an end‑to‑end contract research and development platform that applies modern molecular biology, bioinformatics, and assay technologies to generate and qualify biotech candidates. The service integrates high‑throughput screening, pre‑clinical validation, and data analytics within a GLP/GMP‑compliant framework, accelerating proof‑of‑concept and reducing overall development expense. Clients receive regular progress updates through a secure cloud portal, enabling real‑time monitoring of milestones and data sharing. In addition, Epiphany offers regulatory consulting to streamline IND preparation and facilitate interaction with health authorities. By leveraging proprietary pipelines and scalable laboratory infrastructure, the company helps partners move from target identification to early‑stage development more efficiently.
Target Audience
Primary customers are biotech startups, pharmaceutical R&D divisions, and academic research groups that require outsourced expertise to advance therapeutic or diagnostic candidates through early development stages.
Features
- Automated high‑throughput screening (HTS) system with liquid‑handling robotics and assay miniaturization.
- Integrated bioinformatics suite for target discovery, sequence analysis, and predictive modeling.
- GLP‑compliant in‑vitro and in‑vivo assay libraries covering cell‑based, enzymatic, and biomarker readouts.
- Scalable protein expression and purification platform supporting mammalian, bacterial, and cell‑free systems.
- Regulatory support services, including pre‑IND documentation, toxicology study design, and FDA liaison.
- Secure, role‑based data portal delivering raw data, processed results, analytics dashboards, and audit trails.